Amiodarone-induced skin damage: clinical observation
Year: 2019, volume 15 Issue: №3 Pages: 741-744
Heading: Cardiology Article type: Case report
Authors: Kosheleva N.A., Magdeeva N.A., Frontaseva V.V., Alekseeva I.L., Fedoritova M.O.
Organization: Saratov Regional Clinical Hospital, Saratov State Medical University
Heading: Cardiology Article type: Case report
Authors: Kosheleva N.A., Magdeeva N.A., Frontaseva V.V., Alekseeva I.L., Fedoritova M.O.
Organization: Saratov Regional Clinical Hospital, Saratov State Medical University
Summary:
Nowadays one of the most often used antiarrhytmic drugs is amiodarone. Amiodarone is the most effective drug for sinoatrial rate preservation at fibrillation of auricles, the only agent with the proved ability to reduce mortality in patients with cardial pathology and ventricular arrhythmias. On the other hand, amiodarone is the "reserve" drug due to its side effects. In this observation the patient was on amiodarone in the course of 5 years due to paroxysms of auricles fibrillation. After 4 years of drug therapy grayish-blue local areas appeared on open body parts (i. e. face, hands). After drug with drawal the intensity of skin staining decreased. In this clinical case skin hyperpigmentation was amiodarone side effect and did not require any special treatment.
Keywords: amiodarone, skin hyperpigmentation
Bibliography:
1 Sulimov VA, Golitsyn SP, Panchenko EP Diagnostics and treatment of fibrillation of auricles of 2012 Russian
cardiological magazine 2013; 4: 100
2 Kirchof Р, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation
developed in collaboration with EACTS. Europen Heart Journal 2016; 73 (8): 110
3 Priori SG, Blomstn_(m-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients
with ventricular arrhythmias and the prevention of sudden cardiac death. Heart Journal 2015; 65 (4): 208
4 Ardashev VN, Ardashev AV, Steklov VI. Treatment of violations of a warm rhythm. Moscow: Medpractika,
2005; 227 p.
5 Zadionchenko VS, Belyakova Tl, Arzhaev VI. A skin hyperpegmentation case at prolonged use of a cordarone.
Clinical medicine 1998; 3: 126
6 Reyngardene DI.Axanthopathy at prolonged treatment by amiodarone. The Cardiology 1999; 4: 112-3.
7 Harris L, Roncucci R. Unwanted effects: amiodarone. Paris, 1986; p. 204-69.
8 Minasyan AP, Minasyan RD. An exceptional case of a hyperpegmentation of a skin at long reception of
amiodarone. Heart failure 2005; 2: 102-3.
9 Usha Rao, Ajit Agarwal. Amiodarone-induced facial pigmentation. British Journal of Hospital Medicine 2012;
73 (8): 473
10 Gonzalez-Arriagada FWA, Santos-Silva AR, Vargas PA. Facial pigmentation associated with amiodarone.
General Dentistry 2018; 61 (4): 15-7.
| Attachment | Size |
|---|---|
| 2019_03-1_741-744.pdf | 493.28 KB |
Русский
English